CME vs. NMR: CME vs. Nomura Stock Comparison
How do CME (CME) and Nomura (NMR) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
CME (CME) and Nomura (NMR) both belong to the Capital Markets industry, though CME is classified under Financial Exchanges & Data while NMR falls under Investment Banking & Brokerage.
CME (CME) trades as ordinary local shares, while Nomura (NMR) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.
| Profile Item | CME | NMR |
|---|---|---|
| Name | CME Group Inc. Class A Common Stock | Nomura Holdings, Inc. Sponsored ADR |
| Country/Region | United States | Japan |
| GICS Sector | Financials | Financials |
| GICS Industry Group | Financial Services | Financial Services |
| GICS Industry | Capital Markets | Capital Markets |
| GICS Sub-Industry | Financial Exchanges & Data | Investment Banking & Brokerage |
| Market Capitalization | 109.49 billion USD | 27.53 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | December 6, 2002 | December 17, 2001 |
| Security Type | Common Stock | ADR |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | CME | NMR |
|---|---|---|
| Total Return (1Y) | 14.24% | 35.42% |
| Total Return (3Y, Annualized) | 16.88% | 37.86% |
| Total Return (5Y, Annualized) | 11.09% | 18.78% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | CME | NMR |
|---|---|---|
| Volatility (1Y, Annualized) | 24.87% | 29.52% |
| Beta (5Y) | 0.16 | 0.79 |
| Max Drawdown (5Y) | -31.74% | -38.40% |
| Avg. Volume (3M) | 1.91M | 789.26K |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | CME | NMR |
|---|---|---|
| Sharpe Ratio (1Y) | 0.40 | 1.06 |
| Sortino Ratio (1Y) | 0.56 | 1.55 |
Profitability
ROE (TTM)
Both CME (CME) at 16.13% and Nomura (NMR) at 11.51% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.
CME
Financial Services industry group
16.13%
- Max
- 44.78%
- Q3
- 21.85%
- CME
- 16.13%
- Median
- 12.91%
- Q1
- 4.48%
- Min
- -18.71%
NMR
Financial Services industry group
11.51%
- Max
- 44.78%
- Q3
- 21.85%
- Median
- 12.91%
- NMR
- 11.51%
- Q1
- 4.48%
- Min
- -18.71%
Net Margin (TTM)
CME (CME) at 63.48% converts revenue to bottom-line profit above its industry’s benchmark range, while Nomura (NMR) at 17.12% keeps roughly the typical share for its industry.
CME
Financial Services industry group
63.48%
- CME
- 63.48%
- Max
- 62.84%
- Q3
- 28.05%
- Median
- 15.36%
- Q1
- 4.82%
- Min
- -28.52%
NMR
Financial Services industry group
17.12%
- Max
- 62.84%
- Q3
- 28.05%
- NMR
- 17.12%
- Median
- 15.36%
- Q1
- 4.82%
- Min
- -28.52%
Operating Margin (TTM)
CME (CME) at 65.85% operates in the top operating margin quartile, ahead of Nomura (NMR) at 24.36%, which runs around its industry’s norm.
CME
Financial Services industry group
65.85%
- Max
- 107.33%
- CME
- 65.85%
- Q3
- 55.90%
- Median
- 30.09%
- Q1
- 14.60%
- Min
- -44.34%
NMR
Financial Services industry group
24.36%
- Max
- 107.33%
- Q3
- 55.90%
- Median
- 30.09%
- NMR
- 24.36%
- Q1
- 14.60%
- Min
- -44.34%
Profitability Metrics
| Metric | CME | NMR |
|---|---|---|
| ROE (TTM) | 16.13% | 11.51% |
| ROA (TTM) | 1.52% | 0.68% |
| Net Margin (TTM) | 63.48% | 17.12% |
| Operating Margin (TTM) | 65.85% | 24.36% |
| Gross Margin (TTM) | -- | -- |
Growth
Revenue Growth
Both CME (CME) at 6.37% and Nomura (NMR) at 10.80% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Both CME (CME) at 15.41% and Nomura (NMR) at 7.17% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.
Growth Metrics
| Metric | CME | NMR |
|---|---|---|
| Revenue Growth (YoY) | 6.37% | 10.80% |
| Revenue Growth (3Y CAGR) | 9.11% | 17.17% |
| EPS Growth (YoY) | 15.41% | 7.17% |
| EPS Growth (3Y CAGR) | 14.68% | 58.75% |
Financial Strength
Current Ratio (MRQ)
current ratio doesn’t apply on either side: CME (CME) in Financial Services and Nomura (NMR) in Financial Services both report balance sheets without a current/non-current split, so their short-term liquidity is better judged through regulatory and funding measures.
Debt / Equity (MRQ)
debt-to-equity ratio is set aside for both: CME (CME) in Financial Services and Nomura (NMR) in Financial Services run businesses where balance-sheet leverage is part of the model, so capital-adequacy and funding measures are the better gauges of balance-sheet risk.
Financial Strength Metrics
| Metric | CME | NMR |
|---|---|---|
| Current Ratio (MRQ) | -- | -- |
| Debt / Equity (MRQ) | -- | -- |
| Net Debt / EBITDA | -- | -- |
Dividends
Dividend Yield (TTM)
CME (CME) at 1.68% pays an industry-typical yield; Nomura (NMR) at 620.40% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.
CME
Financial Services industry group
1.68%
- Max
- 9.77%
- Q3
- 3.92%
- CME
- 1.68%
- Median
- 1.09%
- Q1
- 0.00%
- Min
- 0.00%
NMR
Financial Services industry group
620.40%
- NMR
- 620.40%
- Max
- 9.77%
- Q3
- 3.92%
- Median
- 1.09%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both CME (CME) at 92.62% and Nomura (NMR) at 16.85% keep payout ratio within their industries’ typical mid-ranges — dividend policies that share earnings without consuming too much of them.
CME
Financial Services industry group
92.62%
- Max
- 241.07%
- Q3
- 97.36%
- CME
- 92.62%
- Median
- 25.77%
- Q1
- 0.00%
- Min
- 0.00%
NMR
Financial Services industry group
16.85%
- Max
- 241.07%
- Q3
- 97.36%
- Median
- 25.77%
- NMR
- 16.85%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | CME | NMR |
|---|---|---|
| Dividend Yield (TTM) | 1.68% | 620.40% |
| Dividend Payout Ratio (TTM) | 92.62% | 16.85% |
Valuation
P/E Ratio (TTM)
Nomura (NMR) at 10.83 is near its industry’s usual P/E ratio, while CME (CME) at 25.07 sits in the richer quartile — CME needs stronger growth or earnings quality to justify the premium.
CME
Financial Services industry group
25.07
- Max
- 45.85
- CME
- 25.07
- Q3
- 24.64
- Median
- 15.37
- Q1
- 9.68
- Min
- 0.16
NMR
Financial Services industry group
10.83
- Max
- 45.85
- Q3
- 24.64
- Median
- 15.37
- NMR
- 10.83
- Q1
- 9.68
- Min
- 0.16
P/S Ratio (TTM)
Nomura (NMR) at 0.01 sits in the cheaper P/S ratio quartile while CME (CME) at 15.74 prices above its industry range — a wide gap in sales valuation between them.
CME
Financial Services industry group
15.74
- CME
- 15.74
- Max
- 9.23
- Q3
- 4.57
- Median
- 2.72
- Q1
- 1.28
- Min
- -0.55
NMR
Financial Services industry group
0.01
- Max
- 9.23
- Q3
- 4.57
- Median
- 2.72
- Q1
- 1.28
- NMR
- 0.01
- Min
- -0.55
P/B Ratio (MRQ)
Nomura (NMR) at 1.15 is valued about in line with its industry on P/B ratio, while CME (CME) at 4.12 carries an above-peer premium to book — CME is pricier on assets.
CME
Financial Services industry group
4.12
- Max
- 7.79
- CME
- 4.12
- Q3
- 3.63
- Median
- 1.57
- Q1
- 0.81
- Min
- -0.39
NMR
Financial Services industry group
1.15
- Max
- 7.79
- Q3
- 3.63
- Median
- 1.57
- NMR
- 1.15
- Q1
- 0.81
- Min
- -0.39
Valuation Metrics
| Metric | CME | NMR |
|---|---|---|
| P/E Ratio (TTM) | 25.07 | 10.83 |
| P/S Ratio (TTM) | 15.74 | 0.01 |
| P/B Ratio (MRQ) | 4.12 | 1.15 |
| Free Cash Flow Yield (TTM) | -- | -- |